يعرض 1 - 10 نتائج من 24 نتيجة بحث عن '"Dwyer JP"', وقت الاستعلام: 1.47s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المصدر: urn:ISSN:1355-6037 ; urn:ISSN:1468-201X ; Heart, 108, 16, 1281-1289

    وصف الملف: application/pdf

  3. 3
    دورية أكاديمية

    المصدر: urn:ISSN:0140-6736 ; urn:ISSN:1474-547X ; The Lancet, 398, 10305, 1053-1064

    وصف الملف: application/pdf

  4. 4
  5. 5
    دورية أكاديمية
  6. 6
  7. 7
    دورية أكاديمية
  8. 8

    المصدر: Bhatt, D L, Szarek, M, Pitt, B, Cannon, C P, Leiter, L A, McGuire, D K, Lewis, J B, Riddle, M C, Inzucchi, S E, Kosiborod, M N, Cherney, D Z I, Dwyer, J P, Scirica, B M, Bailey, C J, Díaz, R, Ray, K K, Udell, J A, Lopes, R D, Lapuerta, P, Steg, P G & SCORED Investigators 2021, ' Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease ', The New England Journal of Medicine, vol. 384, no. 2, pp. 129-139 . https://doi.org/10.1056/NEJMoa2030186Test
    NEW ENGLAND JOURNAL OF MEDICINE
    r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
    instname

    مصطلحات موضوعية: Male, SAXAGLIPTIN, 030204 cardiovascular system & hematology, Saxagliptin, MELLITUS, chemistry.chemical_compound, 0302 clinical medicine, Settore MED/13, Glycosides, 030212 general & internal medicine, 11 Medical and Health Sciences, RISK, SGLT2 INHIBITOR, OUTCOMES, Kidney, EMPAGLIFLOZIN, General Medicine, Middle Aged, Hospitalization, medicine.anatomical_structure, Cardiovascular Diseases, HEART-FAILURE, Diarrhea/chemically induced, Female, OUTPATIENTS, Life Sciences & Biomedicine, Diarrhea, medicine.medical_specialty, SCORED Investigators, Mycoses/etiology, Diabetic ketoacidosis, Renal Insufficiency, Chronic/complications, Glycosides/adverse effects, Diabetic Ketoacidosis, 03 medical and health sciences, Medicine, General & Internal, Sodium-Glucose Transporter 1, Double-Blind Method, General & Internal Medicine, Internal medicine, Diabetes mellitus, medicine, Empagliflozin, Humans, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, Hospitalization/statistics & numerical data, Science & Technology, Diabetic Ketoacidosis/chemically induced, urogenital system, business.industry, MORTALITY, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, medicine.disease, CARDIOVASCULAR EVENT RATES, Clinical trial, Mycoses, chemistry, Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 1/antagonists & inhibitors, Heart failure, business, Kidney disease

    وصف الملف: application/pdf

  9. 9
    مؤتمر

    وصف الملف: text

    العلاقة: http://livrepository.liverpool.ac.uk/3089266/1/Zelniker%20ESC%20abstract%20DECLARE%20renal%202019.docxTest; Collapse authors list. Zelniker, TA, Raz, I, Mosenzon, O, Dwyer, JP, Heerspink, HJL, Cahn, A, Im, K, Bhatt, DL, Leiter, LA, McGuire, DK et al (show 5 more authors) , Wilding, JPH orcid:0000-0003-2839-8404 , Gause-Nilsson, IAM, Langkilde, AM, Sabatine, MS and Wiviott, SD (2019) Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: Insights from DECLARE-TIMI 58. .

  10. 10